Skip to content
Recall Observatory FDA recall evidence

Drug product

Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01.

D-0546-2024

May 07, 2024

Class II

Product summary

Firm
PACIRA PHARMACEUTICALS INC
Event
Event 94568
Status
Ongoing
Classification
Class II
Quantity
43,768 kits
Official record key
drug-enforcement:D-0546-2024

Official wording

Reason: Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.

Code information: Lot: 082657 (kit 23-9004), Exp: July 2024.

Distribution pattern: U.S. Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Stability Specifications